Robert F. Apple
Director/Board Member chez KAZIA THERAPEUTICS LIMITED
Profil
Robert F.
Apple is a professional with a current job as a Non-Executive Director at Kazia Therapeutics Ltd.
He previously worked as the President, Chief Executive Officer & Director at Antares Pharma, Inc. from 2016 to 2022.
He also held positions as a Director at Kerathin LLC, an Independent Director at PaxMedica, Inc. from 2020 to 2022, and as the Chief Operating & Financial Officer at InKine Pharmaceutical Co., Inc. from 2003 to 2005.
Additionally, he worked as a Controller at Liberty Technologies, Inc. from 1994 to 1995 and at Genaera Corp.
from 1995 to 1997.
Mr. Apple received his undergraduate degree from Temple University (Pennsylvania).
Postes actifs de Robert F. Apple
| Sociétés | Poste | Début |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Director/Board Member | 18/01/2024 |
Anciens postes connus de Robert F. Apple
| Sociétés | Poste | Fin |
|---|---|---|
| ANTARES PHARMA, INC. | Chief Executive Officer | 24/05/2022 |
| PAXMEDICA, INC. | Director/Board Member | 01/04/2022 |
InKine Pharmaceutical Co., Inc.
 InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Director of Finance/CFO | 01/01/2002 |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Comptroller/Controller/Auditor | 01/10/1997 |
| Liberty Technologies, Inc. /Pennsylvania/ | Comptroller/Controller/Auditor | 01/07/1995 |
Formation de Robert F. Apple
| Temple University (Pennsylvania) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| PAXMEDICA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Liberty Technologies, Inc. /Pennsylvania/ | Electronic Technology |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Kerathin LLC
 Kerathin LLC Medical SpecialtiesHealth Technology Kerathin LLC manufactured medical devices for the treatment of diseased and dystrophic nails. It offered podiaPRO-H1, a device that provides improvement in nail debridement. The company was founded by Tom Fitzsimons and Beth Fitzsimons in May 2010 and was headquartered in Chester, PA. | Health Technology |
